Therapeutic approaches for Non-melanoma skin Cancer: Standard of Care and Emerging modalities

S Sol, F Boncimino, K Todorova, SE Waszyn… - International Journal of …, 2024 - mdpi.com
Skin cancer encompasses a range of cutaneous malignancies, with non-melanoma skin
cancers (NMSCs) being the most common neoplasm worldwide. Skin exposure is the …

The current treatment landscape of cutaneous squamous cell carcinoma

CY Chong, MS Goh, SV Porceddu, D Rischin… - American Journal of …, 2023 - Springer
Non-melanoma skin cancers (NMSCs) are the most common form of skin cancer worldwide.
The global incidence of cutaneous squamous cell carcinoma (CSCC) is rising, with an …

Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma

E Russell‐Goldman, JL Hornick… - Journal of Cutaneous …, 2021 - Wiley Online Library
Background Porocarcinoma is the malignant counterpart of poroma, a benign tumor derived
from the eccrine or apocrine units. In contrast to poroma, porocarcinoma is rare and its …

[HTML][HTML] The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review

TM Hosseini, SJ Park, T Guo - Cancers, 2024 - mdpi.com
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is a complex disease arising
from an interplay of UV-induced DNA damage, genetic mutations, and alterations in the …

To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma

M Poole, RA Schwartz, WC Lambert… - Archives of …, 2023 - Springer
Keratoacanthoma (KA) and squamous cell carcinoma (SCC) are rare side effects of
programmed cell death ligand-1 (PD-L1) inhibitors that can disrupt therapy. There is no …

[HTML][HTML] The Role of Gene Expression Profiling in the Management of Cutaneous Squamous Cell Cancer: A Review

RA Durgham, J Badders, SA Nguyen, L Olinde, J Pang… - Cancers, 2024 - mdpi.com
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin
cancer, with an increasing global incidence. While most cases are successfully treated with …

A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma

Y Oh, Z Zheng, KY Kim, X Xu, M Pei, B Oh, SK Kim… - BMC cancer, 2022 - Springer
Background Although determining the recurrence of cutaneous squamous cell carcinoma
(cSCC) is important, currently suggested systems and single biomarkers have limited power …

[HTML][HTML] Oh, the mutations you'll acquire! A systematic overview of cutaneous squamous cell carcinoma

S Droll, X Bao - Cellular physiology and biochemistry: international …, 2021 - ncbi.nlm.nih.gov
Nearly two million cases of cutaneous squamous cell carcinoma (cSCC) are diagnosed
every year in the United States alone. cSCC is notable for both its prevalence and its …

Neurofibromatosis type 1 and risk of skin cancer

P Trinh, S Li, KY Sarin - JAMA dermatology, 2022 - jamanetwork.com
Discussion| Leukopeniaisarelativelycommoncomplicati… in SJS/TEN, which was observed
in 13% of patients at hospital admission. Leukopenia may develop during the acute illness …

REDD1 interacts with AIF and regulates mitochondrial reactive oxygen species generation in the keratinocyte response to UVB

RP Feehan, CS Coleman, S Ebanks, CH Lang… - Biochemical and …, 2022 - Elsevier
Non-melanoma skin cancer (NMSC) incidence is rising, especially in high-risk,
immunocompromised groups such as organ transplant patients, who often develop …